Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Dec;23(4):314-315.
doi: 10.3350/cmh.2017.0110. Epub 2017 Nov 28.

Lamivudine: fading into the mists of time

Jonggi Choi  1 , Young-Suk Lim  1
Affiliations
Editorial

Lamivudine: fading into the mists of time

Jonggi Choi et al. Clin Mol Hepatol. 2017 Dec.
No abstract available

Keywords: Entecavir; Lamivudine; Nucleos(t)ide analogues.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no conflicts to disclose.

Comment on

References

    1. Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis. 2006;26:130–141. - PubMed
    1. Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354:1011–1120. - PubMed
    1. Seto WK, Lam YF, Fung J, Wong DK, Huang FY, Hung IF, et al. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment. J Gastroenterol Hepatol. 2014;29:1028–1034. - PubMed
    1. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261–283. - PMC - PubMed
    1. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1–98. - PMC - PubMed

LinkOut - more resources